Your browser doesn't support javascript.
loading
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning.
Eckardt, Jan-Niklas; Röllig, Christoph; Metzeler, Klaus; Kramer, Michael; Stasik, Sebastian; Georgi, Julia-Annabell; Heisig, Peter; Spiekermann, Karsten; Krug, Utz; Braess, Jan; Görlich, Dennis; Sauerland, Cristina M; Woermann, Bernhard; Herold, Tobias; Berdel, Wolfgang E; Hiddemann, Wolfgang; Kroschinsky, Frank; Schetelig, Johannes; Platzbecker, Uwe; Müller-Tidow, Carsten; Sauer, Tim; Serve, Hubert; Baldus, Claudia; Schäfer-Eckart, Kerstin; Kaufmann, Martin; Krause, Stefan; Hänel, Mathias; Schliemann, Christoph; Hanoun, Maher; Thiede, Christian; Bornhäuser, Martin; Wendt, Karsten; Middeke, Jan Moritz.
Afiliação
  • Eckardt JN; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden. jan-niklas.eckardt@uniklinikum-dresden.de.
  • Röllig C; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden.
  • Metzeler K; Medical Clinic and Policlinic I Hematology and Cell Therapy. University Hospital, Leipzig.
  • Kramer M; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden.
  • Stasik S; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden.
  • Georgi JA; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden.
  • Heisig P; Institute of Software and Multimedia Technology, Technical University Dresden, Dresden.
  • Spiekermann K; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich.
  • Krug U; Medical Clinic III, Hospital Leverkusen, Leverkusen.
  • Braess J; Hospital Barmherzige Brueder Regensburg, Regensburg.
  • Görlich D; Institute for Biometrics and Clinical Research, University Muenster, Muenster.
  • Sauerland CM; Institute for Biometrics and Clinical Research, University Muenster, Muenster.
  • Woermann B; Department of Hematology, Oncology and Tumor Immunology, Charité, Berlin.
  • Herold T; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich.
  • Berdel WE; Department of Internal Medicine A, University Hospital Muenster, Muenster.
  • Hiddemann W; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich.
  • Kroschinsky F; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden.
  • Schetelig J; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden.
  • Platzbecker U; Medical Clinic and Policlinic I Hematology and Cell Therapy. University Hospital, Leipzig.
  • Müller-Tidow C; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany; German Consortium for Translational Cancer Research DKFZ, Heidelberg.
  • Sauer T; Department of Medicine V, University Hospital Heidelberg, Heidelberg.
  • Serve H; Department of Medicine 2, Hematology and Oncology, Goethe University Frankfurt, Frankfurt.
  • Baldus C; Department of Hematology and Oncology, University Hospital Schleswig Holstein, Kiel.
  • Schäfer-Eckart K; Department of Internal Medicine 5, Paracelsus Medical Private University Nuremberg, Nuremberg.
  • Kaufmann M; Department of Hematology, Oncology and Palliative Care, Robert-Bosch Hospital, Stuttgart.
  • Krause S; Department of Internal Medicine 5, University Hospital Erlangen, Erlangen.
  • Hänel M; Department of Internal Medicine 3, Klinikum Chemnitz GmbH, Chemnitz, Germany; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen.
  • Schliemann C; Department of Internal Medicine A, University Hospital Muenster, Muenster.
  • Hanoun M; Department of Internal Medicine 3, Klinikum Chemnitz GmbH, Chemnitz, Germany; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen.
  • Thiede C; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany; German Consortium for Translational Cancer Research DKFZ, Heidelberg.
  • Bornhäuser M; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany; German Consortium for Translational Cancer Research DKFZ, Heidelberg, Germany; National Center for Tumor Diseases (NCT), Dresden.
  • Wendt K; Medical Clinic and Policlinic I Hematology and Cell Therapy. University Hospital, Leipzig.
  • Middeke JM; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden.
Haematologica ; 108(3): 690-704, 2023 03 01.
Article em En | MEDLINE | ID: mdl-35708137
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Nucleofosmina Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Nucleofosmina Idioma: En Ano de publicação: 2023 Tipo de documento: Article